Skip to main content
Log in

Hepatocellular carcinoma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant patients?

  • Original Article
  • Published:
Journal of Hepato-Biliary-Pancreatic Sciences

Abstract

Background/purpose

Hepatocellular carcinoma (HCC) during pregnancy is a very rare condition and is believed to have a worse prognosis than HCC in non-pregnant women. We evaluated the prognosis and the diagnostic and therapeutic strategies for HCC in pregnant women.

Methods

We retrospectively analyzed 4 cases in our hospital and 44 cases described in the medical literature since 1957; we also compared the cases reported before 1995 and those reported during/after 1995.

Results

The overall 6-month and 1-, 2-, and 3-year survival rates in the patients reported in the literature were 50, 29.5, 18.2, and 13.6%, respectively (n = 44). The mean ages at diagnosis before and during/after 1995 were 31.4 ± 7.2 and 28.9 ± 4.4 years, respectively (P = 0.113). The following characteristics were significantly more common in the later group: fewer pregnancies; the absence of advanced signs or symptoms; receipt of therapy; tendency to undergo surgery; and higher 6-month and 1-, 2-, and 3-year survival rates. The median survivals of the groups before and during/after 1995 were 18 and 25.5 months, respectively (P < 0.001).

Conclusions

The morbidity and mortality of HCC during pregnancy has improved over time, as diagnoses have tended to be made earlier and patients have tended to receive surgical and other treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.

    Article  PubMed  Google Scholar 

  2. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817–23.

    PubMed  Google Scholar 

  3. Bosch FX, Ribes J, Daz M, Clries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–16.

    Article  PubMed  Google Scholar 

  4. Lau WY, Leung WT, Ho S, Lam SK, Li CY, Johnson PJ, et al. Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. Cancer. 1995;75:2669–76.

    Article  PubMed  CAS  Google Scholar 

  5. Jeng LB, Lee WC, Wang CC, Chen MF, Hsieh TT. Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein. Am J Obstet Gynecol. 1995;172:219–20.

    Article  PubMed  CAS  Google Scholar 

  6. Gisi P, Floyd R. Hepatocellular carcinoma in pregnancy. A case report. J Reprod Med. 1999;44:65–7.

    PubMed  CAS  Google Scholar 

  7. de la Rosa MA, Nicols-Prez D, Muiz-Montes JR, Trujillo-Carrillo JL. Evolution and management of a hepatocellular carcinoma during pregnancy. J Obstet Gynaecol Res. 2006;32:437–9.

    Article  Google Scholar 

  8. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology. 1998;27:273–8.

    Article  PubMed  CAS  Google Scholar 

  9. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–30.

    Article  PubMed  CAS  Google Scholar 

  10. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.

    Article  PubMed  Google Scholar 

  11. Kim KS, Lee WJ, Kim BR, Cho JS, Han KH. Two cases of the hepatocellular carcinoma in pregnancy. J Korean Surg Soc. 1997;52(4):598–605.

    Google Scholar 

  12. Choi KK, Hong YJ, Choi SB, Yi NJ, Hwang S, Park YN, et al. A case of hepatocellular carcinoma in a pregnant patient in twenties. J Korean Liver Cancer Study Group. 2009;9:76–81.

    Google Scholar 

  13. Kim SI, Han SY, Yun HD, Chun EK, Sang LT, Young LJ, et al. Three cases of primary hepatocellular carcinoma first detected during pregnancy. Korean J Obstet Gynecol. 2000;43(12):2323–7.

    Google Scholar 

  14. Kim DJ, Lee SK, Oh SY, Kang YS, Kim SS, Park JJ, et al. A case of hepatocellular carcinoma associated with oral contraceptives in pregnancy. Korean J Gastroenterol. 1997;30(1):126–30.

    Google Scholar 

  15. Nam SW, Baek JT, Kang SB, Lee DS, Kim JI, Cho SH, et al. A case of the hepatocellular carcinoma during the pregnancy and metastasis to the left atrium. Korean J Hepatol. 2005;11:381–5.

    PubMed  Google Scholar 

  16. Roddie TW. Haemorrhage from primary carcinoma of the liver complicating pregnancy. Br Med J. 1957;1:31.

    Article  PubMed  CAS  Google Scholar 

  17. Yen SS. Spontaneous rupture of the liver during pregnancy. A report of 2 cases. Obstet Gynecol. 1964;23:783–7.

    PubMed  CAS  Google Scholar 

  18. Kim MH, Lin TJ. Silent primary carcinoma of the liver complicating pregnancy: report of a case. Obstet Gynecol. 1965;25:848–52.

    PubMed  CAS  Google Scholar 

  19. Francis TI, Smith JA, Hendrickse JP. Hepatocellular carcinoma in pregnancy. East Afr Med J. 1974;51:789–800.

    PubMed  CAS  Google Scholar 

  20. Purtilo DT, Clark JV, Williams R. Primary hepatic malignancy in pregnant women. Am J Obstet Gynecol. 1975;121:41–4.

    PubMed  CAS  Google Scholar 

  21. Haddow JE, Thompson DK, Kloza EM. Maternal hepatoma detected during serum AFP screening. Lancet. 1980;2:806–7.

    Article  PubMed  CAS  Google Scholar 

  22. Egwuatu VE. Primary hepatocarcinoma in pregnancy. Trans R Soc Trop Med Hyg. 1980;74:793–4.

    Article  PubMed  CAS  Google Scholar 

  23. Christensen SE, Andersen VR, Vilstrup H. A case of hepatoma in pregnancy associated with earlier oral contraception. Acta Obstet Gynecol Scand. 1981;60:519.

    Article  PubMed  CAS  Google Scholar 

  24. Gonçalves CS, Pereira FE, de Vargas PR, Ferreira LS. Hepatocellular carcinoma HBsAg positive in pregnancy. Arq Gastroenterol. 1984;21:75–7.

    PubMed  Google Scholar 

  25. Seaward PG, Koch MA, Mitchell RW, Merrell DA. Primary hepatocellular carcinoma in pregnancy. A case report. S Afr Med J. 1986;69:700–1.

    PubMed  CAS  Google Scholar 

  26. Kroll D, Mazor M, Zirkin H, Schulman H, Glezerman M. Fibrolamellar carcinoma of the liver in pregnancy. A case report. J Reprod Med. 1991;36:823–7.

    PubMed  CAS  Google Scholar 

  27. Goldberg I, Hod M, Katz I, Friedman S, Ovadia J. A case of hepatocellular carcinoma in pregnancy detected by routine screening of maternal alpha-feto-protein. Acta Obstet Gynecol Scand. 1991;70:241–2.

    Article  PubMed  CAS  Google Scholar 

  28. Nganwuchu AM, Ojo OS. Rupture of a nodule of hepatocellular carcinoma simulating uterine rupture in late pregnancy. Trop Doct. 1991;21:45–6.

    PubMed  CAS  Google Scholar 

  29. Ozoh JO, Onuigbo MA, Umerah BC, Mgbor SO. Hepatoma in pregnancy. Trop Geogr Med. 1992;44:72–4.

    PubMed  CAS  Google Scholar 

  30. Pajor A, Szarvas Z, Sotonyi P. Pregnancy in primary liver carcinoma. Int J Gynecol Obstet. 1992;38:235–6.

    Article  CAS  Google Scholar 

  31. To WK, Ghosh A. Primary liver carcinoma complicating pregnancy. Aust N Z J Obstet Gynaecol. 1993;33:325–6.

    Article  PubMed  CAS  Google Scholar 

  32. Wang LR, Jeng CJ, Chu JS. Pregnancy associated with primary hepatocellular carcinoma. Obstet Gynecol. 1993;81:811–3.

    PubMed  CAS  Google Scholar 

  33. Brucker C, Weiss M, Schweiberer L, Genz T, Maasen V, Debus-Thiede G. Hepatocellular carcinoma in pregnancy. Geburtshilfe Frauenheilkd. 1994;54:305–7. (in German).

    Article  PubMed  CAS  Google Scholar 

  34. Hsieh TT, Hou HC, Hsu JJ, Hsieh CC, Jeng LB. Term delivery after hepatocellular carcinoma resection in previous pregnancy. Acta Obstet Gynecol Scand. 1996;75:77–8.

    Article  PubMed  CAS  Google Scholar 

  35. Entezami M, Becker R, Ebert A, Pritze W, Weitzel H. Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy. Gynecol Oncol. 1996;62:405–7.

    Article  PubMed  CAS  Google Scholar 

  36. Hsu KL, Ko SF, Cheng YF, Huang CC. Spontaneous rupture of hepatocellular carcinoma during pregnancy. Obstet Gynecol. 2001;98:913–6.

    Article  PubMed  CAS  Google Scholar 

  37. Louie-Johnsun M, Hewitt P, Perera D, Morris D. Fibrolamellar hepatocellular carcinoma in pregnancy. HPB (Oxford). 2003;5:191–3.

    CAS  Google Scholar 

  38. Ahmed A, Keeffe EB. Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma. J Clin Gastroenterol. 2004;38:135–6.

    Article  PubMed  Google Scholar 

  39. Cheng CH, Rivera AP, Rivera AB, Tenorio JH. Hipglicemia severa como primera manifestacion de Hepatocarcinoma en el embarazo. Rev Gastroenterol (Peru). 2005;25(2):206–9.

    Google Scholar 

  40. Imkie M, Myers SA, Li Y, Fan F, Bennett TL, Forster J, et al. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases. J Reprod Med. 2005;50:633–7.

    PubMed  Google Scholar 

  41. Lee HS, Han CJ, Kim CY. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer. 1993;72:2564–7.

    Article  PubMed  CAS  Google Scholar 

  42. Chang P, Ong W, Lui H, Tan C. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol. 2008;43:881–8.

    Article  PubMed  Google Scholar 

  43. Sherman M. Alphafetoprotein: an obituary. J Hepatol. 2001;34:603–5.

    Article  PubMed  CAS  Google Scholar 

  44. Trevisani F, D’Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol. 2001;34:570–5.

    Article  PubMed  CAS  Google Scholar 

  45. Seppl M, Ruoslahti E. Alpha fetoprotein in maternal serum: a new marker for detection of fetal distress and intrauterine death. Am J Obstet Gynecol. 1973;115:48–52.

    Google Scholar 

  46. Caballero C, Vekemans M, Lopez del Campo JG, Robyn C. Serum alpha-fetoprotein in adults, in women during pregnancy, in children at birth, and during the first week of life: a sex difference. Am J Obstet Gynecol. 1977;127:384–9.

    PubMed  CAS  Google Scholar 

  47. Mizejewski GJ. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv. 2003;58:804–26.

    Article  PubMed  Google Scholar 

  48. Lee HS, Chung YH, Kim CY. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg− patients in the diagnosis of hepatocellular carcinoma. Hepatology. 1991;14:68–72.

    Article  PubMed  CAS  Google Scholar 

  49. Cobey FC, Salem R. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg. 2004;187:181–91.

    Article  PubMed  Google Scholar 

  50. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. 1977;73:386–94.

    PubMed  CAS  Google Scholar 

  51. Heinemann LAJ, DoMinh T, Guggenmoos-Holzmann I, et al. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS). Contraception. 1997;56:275–84.

    Article  Google Scholar 

  52. Mucci LA, Kuper HE, Tamimi R, Lagiou P, Spanos E, Trichopoulos D. Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. BJOG. 2001;108:291–4.

    Article  PubMed  CAS  Google Scholar 

  53. Hsing AW, McLaughlin JK, Hoover RN, Co Chien HT, Blot WJ, Fraumeni JF. Parity and primary liver cancer among young women. J Natl Cancer Inst. 1992;84:1118–9.

    Article  PubMed  CAS  Google Scholar 

  54. De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol. 2002;193:59–63.

    Article  PubMed  Google Scholar 

  55. Stanford JL, Thomas DB. Reproductive factors in the etiology of hepatocellular carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Causes Control. 1992;3:37–42.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A084120).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyung Sik Kim.

About this article

Cite this article

Choi, K.K., Hong, Y.J., Choi, S.B. et al. Hepatocellular carcinoma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant patients?. J Hepatobiliary Pancreat Sci 18, 422–431 (2011). https://doi.org/10.1007/s00534-010-0345-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-010-0345-6

Keywords

Navigation